Literature DB >> 6851420

Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue.

M J Iqbal, B Greenway, M L Wilkinson, P J Johnson, R Williams.   

Abstract

1. Following the finding of high levels of oestrogen receptor proteins in pancreatic carcinoma tissue, two enzymes involved in sex-steroid biosynthetic pathways, aromatase and 5 alpha-reductase, have been measured. 2. Activities of aromatase, which converts testosterone into oestradiol, comparable with those found in pre-menopausal uterus (P less than 0.5) were found in all seven samples of pancreatic carcinoma tissue, and in a pooled sample of foetal pancreas. Measurable but significantly lower activities (P less than 0.001) of aromatase were found in seven specimens of normal pancreas. 3. 5 alpha-Reductase activity, which converts testosterone into the more potent androgen 5 alpha-dihydrotestosterone, was found in malignant pancreatic tissue at approximately half the level found in prostatic tissue (P less than 0.01) and at almost twice the levels found in either normal adult or pooled foetal pancreatic tissue (P less than 0.01). 4. These findings suggest that sex steroids are involved in foetal and adult pancreatic physiology. 5. Since these enzyme pathways are present in pancreatic carcinoma at greater levels than those in normal adult pancreas, it is possible that agents known to interfere with steroid metabolism could be of value in the treatment of this tumour.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851420     DOI: 10.1042/cs0650071

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  20 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells.

Authors:  Xin-Miao Fu; Bao Ting Zhu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-02-21       Impact factor: 4.292

3.  Characteristics of pancreatic carcinoma in the elderly.

Authors:  T Kamisawa; T Yuyang; N Egawa; J Ishiwata; K Tsuruta; A Okamoto; M Koike
Journal:  Int J Pancreatol       Date:  1998-08

Review 4.  Pancreatic cancer: a review of emerging therapies.

Authors:  L Rosenberg
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

5.  Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.

Authors:  Eunjung Lee; Pamela L Horn-Ross; Rudolph P Rull; Susan L Neuhausen; Hoda Anton-Culver; Giske Ursin; Katherine D Henderson; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-09-05       Impact factor: 4.897

Review 6.  Role of Sex Steroids in β Cell Function, Growth, and Survival.

Authors:  Franck Mauvais-Jarvis
Journal:  Trends Endocrinol Metab       Date:  2016-09-15       Impact factor: 12.015

7.  Effects of sex steroid hormones on pancreatic cancer in the rat.

Authors:  D S Longnecker; C Sumi
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

Review 8.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

9.  A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer.

Authors:  Yuqing Zhang; Patricia F Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2009-11-26       Impact factor: 2.506

10.  Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.